Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;8(3):451-66.
doi: 10.1074/mcp.M800231-MCP200. Epub 2008 Nov 4.

Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease

Qiaojun Fang  1 , Andrew Strand, Wendy Law, Vitor M Faca, Matthew P Fitzgibbon, Nathalie Hamel, Benoit Houle, Xin Liu, Damon H May, Gereon Poschmann, Line Roy, Kai Stühler, Wantao Ying, Jiyang Zhang, Zhaobin Zheng, John J M Bergeron, Sam Hanash, Fuchu He, Blair R Leavitt, Helmut E Meyer, Xiaohong Qian, Martin W McIntosh
Affiliations

Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease

Qiaojun Fang et al. Mol Cell Proteomics. 2009 Mar.

Abstract

We integrated five sets of proteomics data profiling the constituents of cerebrospinal fluid (CSF) derived from Huntington disease (HD)-affected and -unaffected individuals with genomics data profiling various human and mouse tissues, including the human HD brain. Based on an integrated analysis, we found that brain-specific proteins are 1.8 times more likely to be observed in CSF than in plasma, that brain-specific proteins tend to decrease in HD CSF compared with unaffected CSF, and that 81% of brain-specific proteins have quantitative changes concordant with transcriptional changes identified in different regions of HD brain. The proteins found to increase in HD CSF tend to be liver-associated. These protein changes are consistent with neurodegeneration, microgliosis, and astrocytosis known to occur in HD. We also discuss concordance between laboratories and find that ratios of individual proteins can vary greatly, but the overall trends with respect to brain or liver specificity were consistent. Concordance is highest between the two laboratories observing the largest numbers of proteins.

PubMed Disclaimer

Figures

F<sc>ig</sc>. 1.
Fig. 1.
Number of total protein groups and genes identified and quantitated by different numbers of methods. Protein groups are in solid bars, and genes are in empty bars.
F<sc>ig</sc>. 2.
Fig. 2.
Patterns of tissue-specific proteins in CSF. A, proteins were sorted in descending order by spectral counts that reflect the relative concentration in CSF with highest concentrations at the top. B, proteins were sorted in descending order by sums of z-scores that indicate the trends of changes in HD-affected individuals relative to control with the most increasing one at the top. Red, brain-specific proteins; green, liver-specific proteins; black, muscle- and heart-specific proteins; white, other tissue-specific proteins.
F<sc>ig</sc>. 3.
Fig. 3.
Correlations of relative protein abundance ratios of two disease statuses among different proteomics methods. Both axes are the following three ratios on a logarithm scale based on different quantitation methods: HD-early/control (A), HD-mid/control (B), and HD-mid/HD-early (C).
See this image and copyright information in PMC

References

    1. The Huntington's Disease Collaborative Research Group ( 1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971–983 - PubMed
    1. Hodges, A., Strand, A. D., Aragaki, A. K., Kuhn, A., Sengstag, T., Hughes, G., Elliston, L. A., Hartog, C., Goldstein, D. R., Thu, D., Hollingsworth, Z. R., Collin, F., Synek, B., Holmans, P. A., Young, A. B., Wexler, N. S., Delorenzi, M., Kooperberg, C., Augood, S. J., Faull, R. L., Olson, J. M., Jones, L., and Luthi-Carter, R. ( 2006) Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet. 15, 965–977 - PubMed
    1. Chan, E. Y., Luthi-Carter, R., Strand, A., Solano, S. M., Hanson, S. A., DeJohn, M. M., Kooperberg, C., Chase, K. O., DiFiglia, M., Young, A. B., Leavitt, B. R., Cha, J. H., Aronin, N., Hayden, M. R., and Olson, J. M. ( 2002) Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. Hum. Mol. Genet. 11, 1939–1951 - PubMed
    1. Strand, A. D., Aragaki, A. K., Shaw, D., Bird, T., Holton, J., Turner, C., Tapscott, S. J., Tabrizi, S. J., Schapira, A. H., Kooperberg, C., and Olson, J. M. ( 2005) Gene expression in Huntington's disease skeletal muscle: a potential biomarker. Hum. Mol. Genet. 14, 1863–1876 - PubMed
    1. Luthi-Carter, R., Hanson, S. A., Strand, A. D., Bergstrom, D. A., Chun, W., Peters, N. L., Woods, A. M., Chan, E. Y., Kooperberg, C., Krainc, D., Young, A. B., Tapscott, S. J., and Olson, J. M. ( 2002) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum. Mol. Genet. 11, 1911–1926 - PubMed

Publication types

Substances